The cagrilintide and semaglutide combination (known as CagriSema) is being studied as a next-generation obesity treatment
GLP-1 hair loss is associated with rapid weight loss (telogen effluvium), not with the GLP-1 drug mechanism itself
The amount of weight loss with semaglutide can vary depending on the dosage, diet, exercise, and individual factors
A recent analysis of the impact of protein intake on lean mass preservation concluded o lder adults retained more lean mass and lost more fat mass during weight loss when consuming higher protein diets . While other studies have found improvements in body composition due to retaining lean mass during energy restriction in young and middle-aged adults
With gastric sleeve or gastric bypass, patients lose about 60% to 70% or even more of excess weight
Once the patient reaches the therapeutic level, the maintenance dose helps maintain drug concentration in the body